393 related articles for article (PubMed ID: 22095251)
1. Personalizing medicine with clinical pharmacogenetics.
Scott SA
Genet Med; 2011 Dec; 13(12):987-95. PubMed ID: 22095251
[TBL] [Abstract][Full Text] [Related]
2. Clinical and regulatory considerations in pharmacogenetic testing.
Schuck RN; Marek E; Rogers H; Pacanowski M
Am J Health Syst Pharm; 2016 Dec; 73(23):1999-2006. PubMed ID: 27864207
[TBL] [Abstract][Full Text] [Related]
3. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
[TBL] [Abstract][Full Text] [Related]
4. Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array.
Johnson JA; Burkley BM; Langaee TY; Clare-Salzler MJ; Klein TE; Altman RB
Clin Pharmacol Ther; 2012 Oct; 92(4):437-9. PubMed ID: 22910441
[TBL] [Abstract][Full Text] [Related]
5. Clinical implementation of genetic testing in medicine: a US regulatory science perspective.
Lesko LJ; Schmidt S
Br J Clin Pharmacol; 2014 Apr; 77(4):606-11. PubMed ID: 24286486
[TBL] [Abstract][Full Text] [Related]
6. Practical considerations for pharmacogenetic testing.
Wedlund PJ
MLO Med Lab Obs; 2001 Sep; 33(9):16-21, 23; quiz 24-5. PubMed ID: 11569125
[No Abstract] [Full Text] [Related]
7. Clinical application of cardiovascular pharmacogenetics.
Voora D; Ginsburg GS
J Am Coll Cardiol; 2012 Jul; 60(1):9-20. PubMed ID: 22742397
[TBL] [Abstract][Full Text] [Related]
8. Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who?
Johnson JA; Weitzel KW
Clin Pharmacol Ther; 2016 Feb; 99(2):154-6. PubMed ID: 26440500
[TBL] [Abstract][Full Text] [Related]
9. Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users.
Chanfreau-Coffinier C; Hull LE; Lynch JA; DuVall SL; Damrauer SM; Cunningham FE; Voight BF; Matheny ME; Oslin DW; Icardi MS; Tuteja S
JAMA Netw Open; 2019 Jun; 2(6):e195345. PubMed ID: 31173123
[TBL] [Abstract][Full Text] [Related]
10. Expectations, validity, and reality in pharmacogenetics.
Limdi NA; Veenstra DL
J Clin Epidemiol; 2010 Sep; 63(9):960-9. PubMed ID: 19995676
[TBL] [Abstract][Full Text] [Related]
11. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM
Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic testing in the Veterans Health Administration (VHA): policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee.
Vassy JL; Stone A; Callaghan JT; Mendes M; Meyer LJ; Pratt VM; Przygodzki RM; Scheuner MT; Wang-Rodriguez J; Schichman SA;
Genet Med; 2019 Feb; 21(2):382-390. PubMed ID: 29858578
[TBL] [Abstract][Full Text] [Related]
13. Horizon Scan Of Clinical Laboratories Offering Pharmacogenetic Testing.
Haga SB; Kantor A
Health Aff (Millwood); 2018 May; 37(5):717-723. PubMed ID: 29733708
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic Pharmacogenetic Prescribing Guidelines for Antidepressants: A Template for Psychiatric Precision Medicine.
Nassan M; Nicholson WT; Elliott MA; Rohrer Vitek CR; Black JL; Frye MA
Mayo Clin Proc; 2016 Jul; 91(7):897-907. PubMed ID: 27289413
[TBL] [Abstract][Full Text] [Related]
15. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
de Leon J; Susce MT; Murray-Carmichael E
Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
[TBL] [Abstract][Full Text] [Related]
16. Challenges in Ordering and Interpreting Pharmacogenomic Tests in Clinical Practice.
Moyer AM; Rohrer Vitek CR; Giri J; Caraballo PJ
Am J Med; 2017 Dec; 130(12):1342-1344. PubMed ID: 28757317
[No Abstract] [Full Text] [Related]
17. Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings.
Chang WC; Tanoshima R; Ross CJD; Carleton BC
Annu Rev Pharmacol Toxicol; 2021 Jan; 61():65-84. PubMed ID: 33006916
[TBL] [Abstract][Full Text] [Related]
18. Is pharmacogenetic CYP2D6 testing useful?
Vetti HH; Molven A; Eliassen AK; Steen VM
Tidsskr Nor Laegeforen; 2010 Nov; 130(22):2224-8. PubMed ID: 21109842
[TBL] [Abstract][Full Text] [Related]
19. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
Hafner S; Haubensak S; Paul T; Zolk O
Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
[No Abstract] [Full Text] [Related]
20. Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene-drug pairs across ambulatory care settings.
Cicali EJ; Weitzel KW; Elsey AR; Orlando FA; Vinson M; Mosley S; Smith DM; Davis R; Drum L; Estores D; Franciosi JP; Hagen MG; Jerkins GJ; Mercado ES; Nainaparampil J; Padron A; Rosenberg EI; Wright A; Schmidt SO; Mathews CA; Cavallari LH; Johnson JA
Genet Med; 2019 Oct; 21(10):2264-2274. PubMed ID: 30926959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
